(VHT) Health Care Shares - Overview

ETF Category: Health | Exchange: NYSE ARCA (USA) | Market Cap: 16.561m USD | Total Return: 16.9% in 12m

Pharmaceuticals, Biotechnology, Medical Devices, Healthcare Services
Total Rating 49
Safety 64
Buy Signal -0.51
Health
Category Rotation: +12.5
TER: 0.10%
AUM: 16.6B
Avg Turnover: 62.4M
Risk 3d forecast
Volatility14.6%
VaR 5th Pctl2.59%
VaR vs Median-1.34%
Reward TTM
Sharpe Ratio0.91
Rel. Str. IBD44
Rel. Str. Peer Group42.9
Character TTM
Beta0.383
Beta Downside0.401
Hurst Exponent0.476
Drawdowns 3y
Max DD16.91%
CAGR/Max DD0.44
CAGR/Mean DD1.42

Warnings

Extended 3d

Tailwinds

No distinct edge detected

Description: VHT Health Care Shares

The Vanguard Health Care Index Fund ETF (VHT) utilizes a full-replication indexing strategy to track the performance of the MSCI US Investable Market Health Care 25/50 Index. The portfolio includes a broad spectrum of U.S. companies across the market-capitalization scale, ranging from large-cap pharmaceutical leaders to small-cap biotechnology firms.

The healthcare sector is characterized by high research and development (R&D) costs and extensive regulatory oversight by the FDA. Companies within this index typically operate across sub-industries such as health insurance, medical device manufacturing, and genomic research, often benefiting from inelastic demand for essential medical services.

As a non-diversified fund, VHT focuses its capital strictly within this single sector, which can lead to higher volatility compared to broad-market indices. Investors can gain deeper insights into these industry-specific risks by reviewing the analytical data on ValueRay. This passive management approach aims to minimize tracking error while providing comprehensive exposure to the domestic healthcare economy.

Headlines to Watch Out For
  • Medicare reimbursement rate adjustments impact profitability of hospital and service providers
  • FDA drug approval cycles dictate valuation swings for major pharmaceutical holdings
  • Rising R&D expenditures for biotechnology firms pressure short term profit margins
  • Aging US demographics drive sustained demand for diagnostic and therapeutic services
  • Federal legislative changes to drug pricing mechanisms threaten core revenue streams
What is the price of VHT shares?

As of June 08, 2026, the stock is trading at USD 284.13 with a total of 405,956 shares traded.
Over the past week, the price has changed by +1.62%, over one month by +4.81%, over three months by -0.05% and over the past year by +16.91%.

Is VHT a buy, sell or hold?

Health Care Shares has no consensus analysts rating.